These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 9631802)
1. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Spapen H; Zhang H; Demanet C; Vleminckx W; Vincent JL; Huyghens L Chest; 1998 Jun; 113(6):1616-24. PubMed ID: 9631802 [TBL] [Abstract][Full Text] [Related]
2. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Zeni F; Pain P; Vindimian M; Gay JP; Gery P; Bertrand M; Page Y; Page D; Vermesch R; Bertrand JC Crit Care Med; 1996 Feb; 24(2):207-14. PubMed ID: 8605790 [TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Rank N; Michel C; Haertel C; Lenhart A; Welte M; Meier-Hellmann A; Spies C Crit Care Med; 2000 Dec; 28(12):3799-807. PubMed ID: 11153617 [TBL] [Abstract][Full Text] [Related]
4. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367 [TBL] [Abstract][Full Text] [Related]
5. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. Kornelisse RF; Hazelzet JA; Savelkoul HF; Hop WC; Suur MH; Borsboom AN; Risseeuw-Appel IM; van der Voort E; de Groot R J Infect Dis; 1996 May; 173(5):1148-56. PubMed ID: 8627066 [TBL] [Abstract][Full Text] [Related]
6. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276 [TBL] [Abstract][Full Text] [Related]
7. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Peake SL; Moran JL; Leppard PI Crit Care Med; 1996 Aug; 24(8):1302-10. PubMed ID: 8706483 [TBL] [Abstract][Full Text] [Related]
8. Prognostic values of serum cytokines in septic shock. Martin C; Saux P; Mege JL; Perrin G; Papazian L; Gouin F Intensive Care Med; 1994; 20(4):272-7. PubMed ID: 8046121 [TBL] [Abstract][Full Text] [Related]
9. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis. Messmann H; Vogt W; Falk W; Vogl D; Zirngibl H; Leser HG; Schölmerich J Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):611-7. PubMed ID: 9855088 [TBL] [Abstract][Full Text] [Related]
10. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock. Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104 [TBL] [Abstract][Full Text] [Related]
11. Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock. Brauner JS; Rohde LE; Clausell N Intensive Care Med; 2000 Mar; 26(3):305-13. PubMed ID: 10823387 [TBL] [Abstract][Full Text] [Related]
12. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Abraham E; Laterre PF; Garbino J; Pingleton S; Butler T; Dugernier T; Margolis B; Kudsk K; Zimmerli W; Anderson P; Reynaert M; Lew D; Lesslauer W; Passe S; Cooper P; Burdeska A; Modi M; Leighton A; Salgo M; Van der Auwera P; Crit Care Med; 2001 Mar; 29(3):503-10. PubMed ID: 11373411 [TBL] [Abstract][Full Text] [Related]
13. [Effects of high volume hemofiltration on hemodynamics and oxygen metabolism at early stage of septic shock in piglet models]. Chen WM; Lu GP; Lu ZJ; Zhang LE Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):819-24. PubMed ID: 24484555 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683 [TBL] [Abstract][Full Text] [Related]
15. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. Domenighetti G; Suter PM; Schaller MD; Ritz R; Perret C J Crit Care; 1997 Dec; 12(4):177-82. PubMed ID: 9459113 [TBL] [Abstract][Full Text] [Related]
16. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock. Avontuur JA; Stam TC; Jongen-Lavrencic M; van Amsterdam JG; Eggermont AM; Bruining HA Intensive Care Med; 1998 Jul; 24(7):673-9. PubMed ID: 9722036 [TBL] [Abstract][Full Text] [Related]
17. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Martin C; Boisson C; Haccoun M; Thomachot L; Mege JL Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763 [TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report. Hein OV; Ohring R; Schilling A; Oellerich M; Armstrong VW; Kox WJ; Spies C Crit Care; 2004 Apr; 8(2):R66-71. PubMed ID: 15025780 [TBL] [Abstract][Full Text] [Related]
19. Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Marecaux G; Pinsky MR; Dupont E; Kahn RJ; Vincent JL Intensive Care Med; 1996 May; 22(5):404-8. PubMed ID: 8796390 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. Watt G; Jongsakul K; Ruangvirayuth R QJM; 2002 May; 95(5):285-90. PubMed ID: 11978899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]